First let’s congratulate the folks at Insulet (NASDAQ: PODD) as this morning the FDA approved the DASH. Per a company issued press release;
“Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced FDA 510(k) clearance of the Omnipod DASHTM Insulin Management System (Omnipod DASH). This clearance lays the foundation for a steady cadence of innovation that furthers Insulet’s mission to empower users to enjoy simplicity, freedom, and healthier lives with their differentiated technology.”
While this is good news for Insulet let . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.